Acta Diabetologica

, Volume 53, Issue 2, pp 271–277 | Cite as

Prevalence of cardiovascular risk factors in youth with type 1 diabetes and elevated body mass index

  • Maria J. Redondo
  • Nicole C. Foster
  • Ingrid M. Libman
  • Sanjeev N. Mehta
  • Joanne M. Hathway
  • Kathleen E. Bethin
  • Brandon M. Nathan
  • Michelle A. Ecker
  • Avni C. Shah
  • Stephanie N. DuBose
  • William V. Tamborlane
  • Robert P. Hoffman
  • Jenise C. Wong
  • David M. Maahs
  • Roy W. Beck
  • Linda A. DiMeglio
Original Article



The prevalence of cardiovascular risk factors in children with type 1 diabetes and elevated BMI in the USA is poorly defined. We aimed to test the hypothesis that children with type 1 diabetes who are overweight or obese have increased frequencies of hypertension, dyslipidemia, and micro-/macroalbuminuria compared to their healthy weight peers.


We studied 11,348 children 2 to <18 years of age enrolled in T1D Exchange between September 2010 and August 2012 with type 1 diabetes for ≥1 year and BMI ≥ 5th age-/sex-adjusted percentile (mean age 12 years, 49 % female, 78 % non-Hispanic White). Overweight and obesity were defined based on Centers for Disease Control and Prevention criteria. Diagnoses of hypertension, dyslipidemia, and micro-/macroalbuminuria were obtained from medical records. Logistic and linear regression models were used to assess factors associated with weight status.


Of the 11,348 participants, 22 % were overweight and 14 % obese. Hypertension and dyslipidemia were diagnosed in 1.0 % and 3.8 % of participants, respectively; micro-/macroalbuminuria was diagnosed in 3.8 % of participants with available data (n = 7,401). The odds of either hypertension or dyslipidemia were higher in obese than healthy weight participants [OR 3.5, 99 % confidence interval (CI) 2.0–6.1 and 2.2, 99 % CI 1.6–3.1, respectively]. Obese participants tended to be diagnosed with micro-/macroalbuminuria less often than healthy weight participants (OR 0.6, 99 % CI 0.4–1.0).


Obese children with type 1 diabetes have a higher prevalence of hypertension and dyslipidemia than healthy weight children with type 1 diabetes. The possible association of obesity with lower micro-/macroalbuminuria rates warrants further investigation.


Obesity Overweight BMI Epidemiology Hypertension Dyslipidemia Micro-albuminuria 



Type 1 diabetes


Body mass index


Cardiovascular disease


Self-monitoring of blood glucose


Hemoglobin A1c



This work was supported through the Leona M. and Harry B. Helmsley Charitable Trust.

Conflict of interest

The authors do not have any conflict of interest.

Ethical standard

This human study has been reviewed by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.

Human and Animal Rights disclosure

All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008.

Informed Consent disclosure

Informed consent was obtained from all patients for being included in the study.

Supplementary material

592_2015_785_MOESM1_ESM.doc (46 kb)
Supplementary material 1 (DOC 45 kb)


  1. 1.
    Minino AM, Murphy SL, Xu J, Kochanek KD (2011) Deaths: final data for 2008. Natl Vital Stat Rep 59(10):1–126Google Scholar
  2. 2.
    Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB et al (2013) Heart disease and stroke statistics—2013 update: a report from the American Heart Association. Circulation 127(1):e6–e245CrossRefPubMedGoogle Scholar
  3. 3.
    Maahs DM, Jalal D, Chonchol M, Johnson RJ, Rewers M, Snell-Bergeon JK (2013) Impaired renal function further increases odds of 6-year coronary artery calcification progression in adults with type 1 diabetes: the CACTI study. Diabetes Care 36(9):2607–2614CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Orchard TJ, Forrest KY, Kuller LH, Becker DJ, Pittsburgh Epidemiology of Diabetes Complications Study (2001) Lipid and blood pressure treatment goals for type 1 diabetes: 10-year incidence data from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Care 24(6):1053–1059CrossRefPubMedGoogle Scholar
  5. 5.
    Pambianco G, Costacou T, Ellis D, Becker DJ, Klein R, Orchard TJ (2006) The 30-year natural history of type 1 diabetes complications: the Pittsburgh Epidemiology of Diabetes Complications Study experience. Diabetes 55(5):1463–1469CrossRefPubMedGoogle Scholar
  6. 6.
    Soedamah-Muthu SS, Fuller JH, Mulnier HE, Raleigh VS, Lawrenson RA, Colhoun HM (2006) High risk of cardiovascular disease in patients with type 1 diabetes in the U.K.: a cohort study using the general practice research database. Diabetes Care 29(4):798–804CrossRefPubMedGoogle Scholar
  7. 7.
    Barzilay JI, Spiekerman CF, Kuller LH, Burke GL, Bittner V, Gottdiener JS et al (2001) Prevalence of clinical and isolated subclinical cardiovascular disease in older adults with glucose disorders: the Cardiovascular Health Study. Diabetes Care 24(7):1233–1239CrossRefPubMedGoogle Scholar
  8. 8.
    Nishimura R, LaPorte RE, Dorman JS, Tajima N, Becker D, Orchard TJ (2001) Mortality trends in type 1 diabetes. The Allegheny County (Pennsylvania) Registry 1965–1999. Diabetes Care 24(5):823–827CrossRefPubMedGoogle Scholar
  9. 9.
    Krantz JS, Mack WJ, Hodis HN, Liu CR, Liu CH, Kaufman FR (2004) Early onset of subclinical atherosclerosis in young persons with type 1 diabetes. J Pediatr 145(4):452–457CrossRefPubMedGoogle Scholar
  10. 10.
    Laing SP, Swerdlow AJ, Slater SD, Burden AC, Morris A, Waugh NR et al (2003) Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes. Diabetologia 46:760–765CrossRefPubMedGoogle Scholar
  11. 11.
    Wood JR, Miller KM, Maahs DM, Beck RW, DiMeglio LA, Libman IM et al (2013) Most youth with type 1 diabetes in the T1D Exchange Clinic Registry do not meet American Diabetes Association or International Society for Pediatric and Adolescent Diabetes clinical guidelines. Diabetes Care 36(7):2035–2037CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Daniels M, DuBose SN, Maahs DM, Beck RW, Fox LA, Gubitosi-Klug R et al (2013) Factors associated with microalbuminuria in 7,549 children and adolescents with type 1 diabetes in the T1D Exchange clinic registry. Diabetes Care 36(9):2639–2645CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Margeirsdottir HD, Larsen JR, Brunborg C, Overby NC, Dahl-Jorgensen K, Norwegian Study Group for Childhood Diabetes (2008) High prevalence of cardiovascular risk factors in children and adolescents with type 1 diabetes: a population-based study. Diabetologia 51(4):554–561CrossRefPubMedGoogle Scholar
  14. 14.
    Peppa-Patrikiou M, Scordili M, Antoniou A, Giannaki M, Dracopoulou M, Dacou-Voutetakis C (1998) Carotid atherosclerosis in adolescents and young adults with IDDM. Relation to urinary endothelin, albumin, free cortisol, and other factors. Diabetes Care 21(6):1004–1007CrossRefPubMedGoogle Scholar
  15. 15.
    Kaminski BM, Klingensmith GJ, Beck RW, Tamborlane WV, Lee J, Hassan K et al (2013) Body mass index at the time of diagnosis of autoimmune type 1 diabetes in children. J Pediatr 162(4):736–740CrossRefPubMedGoogle Scholar
  16. 16.
    Liu LL, Lawrence JM, Davis C, Liese AD, Pettitt DJ, Pihoker C et al (2010) Prevalence of overweight and obesity in youth with diabetes in USA: the SEARCH for Diabetes in Youth study. Pediatr Diabetes 11(1):4–11CrossRefPubMedGoogle Scholar
  17. 17.
    Purnell JQ, Zinman B, Brunzell JD (2013) The effect of excess weight gain with intensive diabetes mellitus treatment on cardiovascular disease risk factors and atherosclerosis in type 1 diabetes mellitus: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC) study. Circulation 127(2):180–187CrossRefPubMedGoogle Scholar
  18. 18.
    Carmona-Cejudo JM, Hortas ML, Baena-Garcia M, Lana-Linati J, Gonzalez C, Redondo M et al (2012) DB4US: a Decision Support System for Laboratory Information Management. Interact J Med Res 1(2):e16CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Goodman E, Dolan LM, Morrison JA, Daniels SR (2005) Factor analysis of clustered cardiovascular risks in adolescence: obesity is the predominant correlate of risk among youth. Circulation 111(15):1970–1977CrossRefPubMedGoogle Scholar
  20. 20.
    Kavey RE, Allada V, Daniels SR, Hayman LL, McCrindle BW, Newburger JW et al (2006) Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation 114(24):2710–2738CrossRefPubMedGoogle Scholar
  21. 21.
    Redondo MJ, Rodriguez LM, Escalante M, O’Brian Smith E, Balasubramanyam A, Haymond MW (2012) Beta cell function and BMI in ethnically diverse children with newly diagnosed autoimmune type 1 diabetes. Pediatr Diabetes 13(7):564–571CrossRefPubMedGoogle Scholar
  22. 22.
    Libman IM, Pietropaolo M, Arslanian SA, LaPorte RE, Becker DJ (2003) Changing prevalence of overweight children and adolescents at onset of insulin-treated diabetes. Diabetes Care 26(10):2871–2875CrossRefPubMedGoogle Scholar
  23. 23.
    Sandhu N, Witmans MB, Lemay JF, Crawford S, Jadavji N, Pacaud D (2008) Prevalence of overweight and obesity in children and adolescents with type 1 diabetes mellitus. J Pediatr Endocrinol Metab 21(7):631–640CrossRefPubMedGoogle Scholar
  24. 24.
    Beck RW, Tamborlane WV, Bergenstal RM, Miller KM, Dubose SN, Hall CA (2012) The T1D Exchange clinic registry. J Clin Endocrinol Metab 97(12):4383–4389CrossRefPubMedGoogle Scholar
  25. 25.
    Kuczmarski RJ, Ogden CL, Guo SS, Grummer-Strawn LM, Flegal KM, Mei Z, Wei R et al (2002) CDC growth charts for the United States: methods and development. National Center for Health Statistics. Vital Health Stat 11(246):1–190Google Scholar
  26. 26.
    Barlow SE, Expert C (2007) Expert committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report. Pediatrics 120(Suppl 4):S164–S192CrossRefPubMedGoogle Scholar
  27. 27.
    Ogden CL, Carroll MD, Kit BK, Flegal KM (2014) Prevalence of childhood and adult obesity in the United States, 2011–2012. JAMA 311(8):806–814CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Anderson J, Pena AS, Sullivan T, Gent R, D’Arcy B, Olds T et al (2013) Does metformin improve vascular health in children with type 1 diabetes? Protocol for a one year, double blind, randomised placebo controlled trial. BMC Pediatr 13:108CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Liu C, Wu D, Zheng X, Li P, Li L (2015) Efficacy and safety of metformin for patients with type 1 diabetes: a meta-analysis. Diabetes Technol Ther 17:142–148CrossRefPubMedGoogle Scholar
  30. 30.
    Maahs DM, Snively BM, Bell RA, Dolan L, Hirsch I, Imperatore G et al (2007) Higher prevalence of elevated albumin excretion in youth with type 2 than type 1 diabetes: the SEARCH for Diabetes in Youth study. Diabetes Care 30(10):2593–2598CrossRefPubMedGoogle Scholar
  31. 31.
    Loghman-Adham M (1998) Evaluating proteinuria in children. Am Fam Physician 58(5):1145–1152, 1158–1159Google Scholar
  32. 32.
    Springberg PD, Garrett LE Jr, Thompson AL Jr, Collins NF, Lordon RE, Robinson RR (1982) Fixed and reproducible orthostatic proteinuria: results of a 20-year follow-up study. Ann Intern Med 97(4):516–519CrossRefPubMedGoogle Scholar
  33. 33.
    TODAY Study Group (2013) Retinopathy in youth with type 2 diabetes participating in the TODAY clinical trial. Diabetes Care 36(6):1772–1774CrossRefPubMedCentralGoogle Scholar
  34. 34.
    Mohebi R, Simforoosh A, Tohidi M, Azizi F, Hadaegh F (2015) Obesity paradox and risk of mortality events in chronic kidney disease patients: A decade of follow-up in Tehran Lipid and Glucose Study. J Ren Nutr. doi: 10.1053/jrn.2014.12.006 PubMedGoogle Scholar
  35. 35.
    TODAY Study Group (2013) Rapid rise in hypertension and nephropathy in youth with type 2 diabetes: the TODAY clinical trial. Diabetes Care 36:1735–1741CrossRefPubMedCentralGoogle Scholar
  36. 36.
    van Vliet M, Van der Heyden JC, Diamant M, Von Rosenstiel IA, Schindhelm RK, Aanstoot HJ et al (2010) Overweight is highly prevalent in children with type 1 diabetes and associates with cardiometabolic risk. J Pediatr 156(6):923–929CrossRefPubMedGoogle Scholar
  37. 37.
    Perkins BA, Ficociello LH, Silva KH, Finkelstein DM, Warram JH, Krolewski AS (2003) Regression of microalbuminuria in type 1 diabetes. N Engl J Med 348:2285–2293CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Italia 2015

Authors and Affiliations

  • Maria J. Redondo
    • 1
  • Nicole C. Foster
    • 2
  • Ingrid M. Libman
    • 3
  • Sanjeev N. Mehta
    • 4
  • Joanne M. Hathway
    • 4
  • Kathleen E. Bethin
    • 5
  • Brandon M. Nathan
    • 6
  • Michelle A. Ecker
    • 5
  • Avni C. Shah
    • 7
  • Stephanie N. DuBose
    • 2
  • William V. Tamborlane
    • 8
  • Robert P. Hoffman
    • 9
  • Jenise C. Wong
    • 10
  • David M. Maahs
    • 11
  • Roy W. Beck
    • 2
  • Linda A. DiMeglio
    • 12
  1. 1.Baylor College of MedicineHoustonUSA
  2. 2.Jaeb Center for Health ResearchTampaUSA
  3. 3.Children’s Hospital of Pittsburgh of UPMCPittsburghUSA
  4. 4.Joslin Diabetes CenterBostonUSA
  5. 5.School of Medicine and Biomedical Sciences at the University at BuffaloState University of New YorkBuffaloUSA
  6. 6.University of MinnesotaMinneapolisUSA
  7. 7.Stanford University School of MedicineStanfordUSA
  8. 8.Yale UniversityNew HavenUSA
  9. 9.Nationwide Children’s HospitalColumbusUSA
  10. 10.University of California at San FranciscoSan FranciscoUSA
  11. 11.Barbara Davis Center for Childhood DiabetesAuroraUSA
  12. 12.Indiana University School of MedicineIndianapolisUSA

Personalised recommendations